Mark Blumling

Mark Blumling

Directeur/Membre du Conseil chez Data Cubed LLC

Health Technology
Commercial Services
Consumer Services

Profil

Mark Blumling was the founder of Hyperion Therapeutics, Inc. (founded in 2006) and Headlands Research, Inc. (founded in 2018), where he held the titles of Chief Operating Officer and President, Chief Executive Officer & Director, respectively.
Currently, he is a Director at Data Cubed LLC since 2023.
Mr. Blumling's former positions include Chief Executive Officer at RedBrick Health Corp., Relevare Aust Pty Ltd., and Relevare Pharmaceuticals Ltd., Chief Executive Officer at Genos Research, Inc., Director-Strategy & Business Development at Orchid Cellmark, Inc., and Director at Signature Therapeutics, Inc., Burrill LLC, and GlaxoSmithKline LLC.
Mr. Blumling's education includes an undergraduate degree from Stanford University, a graduate degree from the London School of Economics & Political Science, and a graduate degree from Stanford Law School.

Postes actifs de Mark Blumling

SociétésPosteDébut
Directeur/Membre du Conseil 08/02/2023
Tous les postes actifs de Mark Blumling

Anciens postes connus de Mark Blumling

SociétésPosteFin
Directeur Général -
Directeur/Membre du Conseil -
Fondateur -
Directeur Général -
Directeur/Membre du Conseil -
Voir l'expérience en détail de Mark Blumling

Formation de Mark Blumling

Stanford University Undergraduate Degree
London School of Economics & Political Science Graduate Degree
Stanford Law School Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Mark Blumling

Relations

6

Relations au 1er degré

14

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées11

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Finance

Commercial Services

Commercial Services

Technology Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Mark Blumling